français | english		EPFL > people@EPFL > Ruben Hartkoorn login

Scientist SV GHI UPCOL

Ruben Hartkoorn Prof. Cole Group office(s): SV3533 phone(s): [+41 21 69] 31772 MAIN PUBLICATIONS C. Sala and R. C. Hartkoorn. Tuberculosis drugs: new candidates and how to find more. Future microbiology, 6(6):617-33, 2011. [ DOI | Details ] C. Sala and R. C. Hartkoorn. Tuberculosis drugs: new candidates and how to find more. 2011. [ DOI | Details ] S. Magnet, R. C. Hartkoorn, R. Székely, J. Pató, J. A. Triccas, P. Schneider, C. Szántai-Kis, L. Orfi, M. Chambon, D. Banfi, M. Bueno, G. Turcatti, G. Kéri, and S. T. Cole. Leads for antitubercular compounds from kinase inhibitor library screens. Tuberculosis, 90(6):354-60, 2010. [ DOI | Details ] C. Sala, N. Dhar, R. C. Hartkoorn, M. Zhang, Y. H. Ha, P. Schneider, and S. T. Cole. A Simple Model for Testing Drugs against Non-replicating Mycobacterium tuberculosis. Antimicrobial agents and chemotherapy, 2010. [ DOI | Details ] R. C. Hartkoorn, C. Sala, S. J. Magnet, J. M. Chen, F. Pojer, and S. T. Cole. Sigma Factor F does not Prevent Rifampin Inhibition of RNA Polymerase or Cause Rifampin Tolerance in Mycobacterium tuberculosis. Journal of bacteriology, 2010. [ DOI | Details ] W. S. Kwan, O. Janneh, R. Hartkoorn, B. Chandler, S. Khoo, D. Back, and A. Owen. Intracellular 'boosting' of darunavir using known transport inhibitors in primary PBMC. British Journal Of Clinical Pharmacology, 68:375-380, 2009. [ DOI | Details ]